Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480620 · ClinicalTrials.gov registry record · NA
Post Discharge Online Telerehabilitation Program
A NA study, sponsored by Brooks Rehabilitation.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03480620: Clinical Trial NA study, sponsored by Brooks Rehabilitation.
NCT03480620 is a NA study that was terminated before completion, run by Brooks Rehabilitation. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03480620, a NA study, was terminated before completion, sponsored by Brooks Rehabilitation.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will evaluate the sustainability of pain and functional outcomes along with return to opioid use in a population of patients that successfully completed a comprehensive interdisciplinary pain rehabilitation program. In addition, this study will compare outcomes sustainability and return to opioid use between pain program graduates who receive post discharge self-management resources consisting of a DVD with videos of recommended flexibility practice (standard of care) or access to an online telerehabilitation platform that provides patients with access to the flexibility practice videos on a variety of telecommunication devices (e.g., computer, smart phone, tablet).
Primary Outcome
Self-reported home exercise program adherence. Utilization data from the online telerehabilitation platform will also be collected for the telerehabilitation group.
Interventions
- OTHER Usual care
- OTHER Online Telerehabilitation Platform Access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Why NCT03480620 stopped before completion
NCT03480620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT03480620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03480620 about?
NCT03480620 is a clinical study titled "Post Discharge Online Telerehabilitation Program". This study will evaluate the sustainability of pain and functional outcomes along with return to opioid use in a population of patients that successfully completed a comprehensive interdisciplinary pain rehabilitation program. In addition, this study will compare outcomes sustainability and return t...
What is the current status of trial NCT03480620?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2018-02-09. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03480620?
The interventions under investigation include: Usual care (OTHER), Online Telerehabilitation Platform Access (OTHER).
Who is sponsoring clinical trial NCT03480620?
This trial is sponsored by Brooks Rehabilitation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03480620's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI